Parathyroid Disorders Market SWOT Analysis by 2031
The Parathyroid Disorders Market is expected to register a CAGR of 6.7% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report undertakes a comprehensive analysis of the Parathyroid Disorders market, surveying its current state and future trends and actual driving factors. The report details the different types of parathyroid disorders, such as primary hyperparathyroidism, secondary hyperparathyroidism, and hypoparathyroidism, their symptoms, and associated complications. The study further explores the diagnostic methods used for these disorders, which include blood tests, imaging studies, and genetic testing. The treatment options available, including medical management, surgical interventions, and emerging therapies, are also considered in the report. This report further examines the market landscape, the key players, and their strategies and competitive dynamics. This report is used as a value source for stakeholders in the healthcare industry - the pharmaceutical companies, medical device manufacturers, healthcare providers, and investors - through insights into the market size, growth prospects, and regional trends.
Purpose of the ReportThe report Parathyroid Disorders Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Parathyroid Disorders Market Segmentation
Type- Hyperparathyroidism Parathyroid Cancer
- Hypoparathyroidism
- Blood Tests
- Imaging Tests
- Urine Tests
- Surgery
- Radiation Therapy
- Drugs
- Hospitals and Clinics
- Diagnostic Centers
- Drug Stores
- Pharmacies
- Hospitals and Clinics
- Diagnostic Centers
- Drug Stores
- Pharmacies
Strategic Insights
Parathyroid Disorders Market Growth Drivers- Rising Incidences of parathyroid: Several influential factors have been pushing the parathyroid disorders market upward. The incidence rate has been observed to be highly increased among the aging population. As people stay healthier for longer, the chances of them getting afflicted by age-related diseases like parathyroid disorders go up.
- Improved Diagnostic Methodology: Better technologies that evolve with time improve diagnostic methodologies which include blood tests and imaging studies, thus helping determine the conditions resulting from parathyroid disorders earlier and more accurately. This has increased the cure rate for the conditions under discussion.
- Growing Awareness: Growing awareness among healthcare providers and the public at large regarding parathyroid diseases accelerates the urgent demand for viable treatment solutions. This is yet further accelerated by increased healthcare spending and efforts by the government toward increasing access to healthcare facilities. However, in addition to all these, there is still research coming in on new and innovative therapies and surgical procedures. Personalized medicine is gaining momentum, and this trend further supports growth within this market.
- Advancements in Drug Development: Innovations in therapeutic options, including calcimimetics, parathyroid hormone (PTH) analogs, and biologics, offer opportunities to address unmet needs in managing these disorders.
- Advancements in Minimally Invasive Surgical Techniques: Further definition of the future of this parathyroid disorders market will be made by advancement in minimally invasive surgical techniques, such as robotic surgery and video-assisted parathyroidectomy, that will improve patient outcomes and reduce recovery time. Additional channels for patients who are not good surgical candidates have been opened by new medical therapies, such as calcimimetics and bisphosphonates for the treatment of secondary hyperparathyroidism. Advances in technologies that would increase access, especially for all underserved areas, have brought about more uptakes of telemedicine and remote patient monitoring.
- Personalised Medicines: Rising emphasis on personalized medicine and focusing on the precision medicine approach will empower further strategies based on the specifics of individual patients for individualized therapy approaches. Continuous research unraveling mechanisms underlying these parathyroid disorders would surely be followed by targeted therapies and preventive interventions.
- Development of Combination Therapies: Combining PTH analogs with vitamin D analogs or other medications to optimize treatment outcomes offers a promising avenue for new product development.
- Advancement in diagnostic: The parathyroid disorders market remains vast and has lots of scope for growth and innovation. Parathyroid disorders are increasingly common, and advancement in diagnostic and therapeutic technologies holds lots of promise. Continually improving with minimal surgical techniques, especially with robotic surgery, the patient outcomes will continue to improve while the periods of recovery shorten. It has introduced drugs such as calcimimetics and bisphosphonates into emerging fields of medicine, which shall be used in poor surgical candidates as a second-line therapy.
- Growing interest in Individualization: There is an increasingly growing interest in individualization and precision medicine. The successful introduction of targeted therapies demonstrates an interest in such a strategy based on the needs of a specific patient.
- Integration of Technology: Telemedicine and remote patient monitoring may increase the availability of care for such underserved areas. These trends open up market players a chance to meet and expand the demand for effective treatments and diagnostic tools by those suffering from disorders of parathyroids.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Parathyroid Disorders Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Parathyroid Disorders Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Parathyroid Disorders Market is expected to grow at a CAGR of 6.7% between 2023-2031
Driving Factors of the Parathyroid Disorders Market: The growing population of the aged is on the leading edge in terms of increasing prevalence of parathyroid disorders. The advancement in diagnostic techniques like blood tests and imaging studies has enabled better and earlier diagnosis. Increasing expenditure on healthcare, as well as efforts from the government to enhance health care accessibility, also catalyze market growth. Developing innovative therapies and surgical techniques, as well as the intensifying focus on personalized medicine, are expected to propel future market growth.
The future of the parathyroid disorders market is influenced by several trends. Improved patient outcomes through the advancement of minimally invasive surgical techniques, such as robotic surgery, are driving the market forward. Novel medical therapies, including calcimimetics and bisphosphonates, open up new treatment channels. Improvements in patient access with telemedicine and remote monitoring further advance the space. Moving forward, increased personalization will be realized, enabling more tailored treatment strategies. Further research and discovery of targeted therapies and preventive interventions will ultimately push market growth forward.
The leading players of the market are: Alcon Laboratories, Inc., Amgen Inc., Bayer Healthcare, Becton, Dickinson and Company, Ethicon, Inc., Medtronic Merck, Smith & Nephew plc, Teva Pharmaceutical Industries Ltd.
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Parathyroid Disorders Market - By Type
1.3.2 Parathyroid Disorders Market - By Diagnosis
1.3.3 Parathyroid Disorders Market - By Treatment
1.3.4 Parathyroid Disorders Market - By End User
1.3.5 Parathyroid Disorders Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PARATHYROID DISORDERS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PARATHYROID DISORDERS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. PARATHYROID DISORDERS MARKET - GLOBAL MARKET ANALYSIS
6.1. PARATHYROID DISORDERS - GLOBAL MARKET OVERVIEW
6.2. PARATHYROID DISORDERS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. PARATHYROID DISORDERS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. HYPERPARATHYROIDISM (HPT)
7.3.1. Overview
7.3.2. Hyperparathyroidism (HPT) Market Forecast and Analysis
7.4. PARATHYROID CANCER
7.4.1. Overview
7.4.2. Parathyroid Cancer Market Forecast and Analysis
7.5. HYPOPARATHYROIDISM
7.5.1. Overview
7.5.2. Hypoparathyroidism Market Forecast and Analysis
8. PARATHYROID DISORDERS MARKET - REVENUE AND FORECASTS TO 2028 - DIAGNOSIS
8.1. OVERVIEW
8.2. DIAGNOSIS MARKET FORECASTS AND ANALYSIS
8.3. BLOOD TESTS
8.3.1. Overview
8.3.2. Blood Tests Market Forecast and Analysis
8.4. IMAGING TESTS
8.4.1. Overview
8.4.2. Imaging Tests Market Forecast and Analysis
8.5. URINE TESTS
8.5.1. Overview
8.5.2. Urine Tests Market Forecast and Analysis
9. PARATHYROID DISORDERS MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT
9.1. OVERVIEW
9.2. TREATMENT MARKET FORECASTS AND ANALYSIS
9.3. SURGERY
9.3.1. Overview
9.3.2. Surgery Market Forecast and Analysis
9.4. RADIATION THERAPY
9.4.1. Overview
9.4.2. Radiation Therapy Market Forecast and Analysis
9.5. DRUGS
9.5.1. Overview
9.5.2. Drugs Market Forecast and Analysis
9.6. OTHERS
9.6.1. Overview
9.6.2. Others Market Forecast and Analysis
10. PARATHYROID DISORDERS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. HOSPITALS AND CLINICS
10.3.1. Overview
10.3.2. Hospitals and Clinics Market Forecast and Analysis
10.4. DIAGNOSTIC CENTERS
10.4.1. Overview
10.4.2. Diagnostic Centers Market Forecast and Analysis
10.5. DRUG STORES
10.5.1. Overview
10.5.2. Drug Stores Market Forecast and Analysis
10.6. PHARMACIES
10.6.1. Overview
10.6.2. Pharmacies Market Forecast and Analysis
10.7. OTHERS
10.7.1. Overview
10.7.2. Others Market Forecast and Analysis
11. PARATHYROID DISORDERS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Parathyroid Disorders Market Overview
11.1.2 North America Parathyroid Disorders Market Forecasts and Analysis
11.1.3 North America Parathyroid Disorders Market Forecasts and Analysis - By Type
11.1.4 North America Parathyroid Disorders Market Forecasts and Analysis - By Diagnosis
11.1.5 North America Parathyroid Disorders Market Forecasts and Analysis - By Treatment
11.1.6 North America Parathyroid Disorders Market Forecasts and Analysis - By End User
11.1.7 North America Parathyroid Disorders Market Forecasts and Analysis - By Countries
11.1.7.1 United States Parathyroid Disorders Market
11.1.7.1.1 United States Parathyroid Disorders Market by Type
11.1.7.1.2 United States Parathyroid Disorders Market by Diagnosis
11.1.7.1.3 United States Parathyroid Disorders Market by Treatment
11.1.7.1.4 United States Parathyroid Disorders Market by End User
11.1.7.2 Canada Parathyroid Disorders Market
11.1.7.2.1 Canada Parathyroid Disorders Market by Type
11.1.7.2.2 Canada Parathyroid Disorders Market by Diagnosis
11.1.7.2.3 Canada Parathyroid Disorders Market by Treatment
11.1.7.2.4 Canada Parathyroid Disorders Market by End User
11.1.7.3 Mexico Parathyroid Disorders Market
11.1.7.3.1 Mexico Parathyroid Disorders Market by Type
11.1.7.3.2 Mexico Parathyroid Disorders Market by Diagnosis
11.1.7.3.3 Mexico Parathyroid Disorders Market by Treatment
11.1.7.3.4 Mexico Parathyroid Disorders Market by End User
11.2. EUROPE
11.2.1 Europe Parathyroid Disorders Market Overview
11.2.2 Europe Parathyroid Disorders Market Forecasts and Analysis
11.2.3 Europe Parathyroid Disorders Market Forecasts and Analysis - By Type
11.2.4 Europe Parathyroid Disorders Market Forecasts and Analysis - By Diagnosis
11.2.5 Europe Parathyroid Disorders Market Forecasts and Analysis - By Treatment
11.2.6 Europe Parathyroid Disorders Market Forecasts and Analysis - By End User
11.2.7 Europe Parathyroid Disorders Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Parathyroid Disorders Market
11.2.7.1.1 Germany Parathyroid Disorders Market by Type
11.2.7.1.2 Germany Parathyroid Disorders Market by Diagnosis
11.2.7.1.3 Germany Parathyroid Disorders Market by Treatment
11.2.7.1.4 Germany Parathyroid Disorders Market by End User
11.2.7.2 France Parathyroid Disorders Market
11.2.7.2.1 France Parathyroid Disorders Market by Type
11.2.7.2.2 France Parathyroid Disorders Market by Diagnosis
11.2.7.2.3 France Parathyroid Disorders Market by Treatment
11.2.7.2.4 France Parathyroid Disorders Market by End User
11.2.7.3 Italy Parathyroid Disorders Market
11.2.7.3.1 Italy Parathyroid Disorders Market by Type
11.2.7.3.2 Italy Parathyroid Disorders Market by Diagnosis
11.2.7.3.3 Italy Parathyroid Disorders Market by Treatment
11.2.7.3.4 Italy Parathyroid Disorders Market by End User
11.2.7.4 Spain Parathyroid Disorders Market
11.2.7.4.1 Spain Parathyroid Disorders Market by Type
11.2.7.4.2 Spain Parathyroid Disorders Market by Diagnosis
11.2.7.4.3 Spain Parathyroid Disorders Market by Treatment
11.2.7.4.4 Spain Parathyroid Disorders Market by End User
11.2.7.5 United Kingdom Parathyroid Disorders Market
11.2.7.5.1 United Kingdom Parathyroid Disorders Market by Type
11.2.7.5.2 United Kingdom Parathyroid Disorders Market by Diagnosis
11.2.7.5.3 United Kingdom Parathyroid Disorders Market by Treatment
11.2.7.5.4 United Kingdom Parathyroid Disorders Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Parathyroid Disorders Market Overview
11.3.2 Asia-Pacific Parathyroid Disorders Market Forecasts and Analysis
11.3.3 Asia-Pacific Parathyroid Disorders Market Forecasts and Analysis - By Type
11.3.4 Asia-Pacific Parathyroid Disorders Market Forecasts and Analysis - By Diagnosis
11.3.5 Asia-Pacific Parathyroid Disorders Market Forecasts and Analysis - By Treatment
11.3.6 Asia-Pacific Parathyroid Disorders Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Parathyroid Disorders Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Parathyroid Disorders Market
11.3.7.1.1 Australia Parathyroid Disorders Market by Type
11.3.7.1.2 Australia Parathyroid Disorders Market by Diagnosis
11.3.7.1.3 Australia Parathyroid Disorders Market by Treatment
11.3.7.1.4 Australia Parathyroid Disorders Market by End User
11.3.7.2 China Parathyroid Disorders Market
11.3.7.2.1 China Parathyroid Disorders Market by Type
11.3.7.2.2 China Parathyroid Disorders Market by Diagnosis
11.3.7.2.3 China Parathyroid Disorders Market by Treatment
11.3.7.2.4 China Parathyroid Disorders Market by End User
11.3.7.3 India Parathyroid Disorders Market
11.3.7.3.1 India Parathyroid Disorders Market by Type
11.3.7.3.2 India Parathyroid Disorders Market by Diagnosis
11.3.7.3.3 India Parathyroid Disorders Market by Treatment
11.3.7.3.4 India Parathyroid Disorders Market by End User
11.3.7.4 Japan Parathyroid Disorders Market
11.3.7.4.1 Japan Parathyroid Disorders Market by Type
11.3.7.4.2 Japan Parathyroid Disorders Market by Diagnosis
11.3.7.4.3 Japan Parathyroid Disorders Market by Treatment
11.3.7.4.4 Japan Parathyroid Disorders Market by End User
11.3.7.5 South Korea Parathyroid Disorders Market
11.3.7.5.1 South Korea Parathyroid Disorders Market by Type
11.3.7.5.2 South Korea Parathyroid Disorders Market by Diagnosis
11.3.7.5.3 South Korea Parathyroid Disorders Market by Treatment
11.3.7.5.4 South Korea Parathyroid Disorders Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Parathyroid Disorders Market Overview
11.4.2 Middle East and Africa Parathyroid Disorders Market Forecasts and Analysis
11.4.3 Middle East and Africa Parathyroid Disorders Market Forecasts and Analysis - By Type
11.4.4 Middle East and Africa Parathyroid Disorders Market Forecasts and Analysis - By Diagnosis
11.4.5 Middle East and Africa Parathyroid Disorders Market Forecasts and Analysis - By Treatment
11.4.6 Middle East and Africa Parathyroid Disorders Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Parathyroid Disorders Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Parathyroid Disorders Market
11.4.7.1.1 South Africa Parathyroid Disorders Market by Type
11.4.7.1.2 South Africa Parathyroid Disorders Market by Diagnosis
11.4.7.1.3 South Africa Parathyroid Disorders Market by Treatment
11.4.7.1.4 South Africa Parathyroid Disorders Market by End User
11.4.7.2 Saudi Arabia Parathyroid Disorders Market
11.4.7.2.1 Saudi Arabia Parathyroid Disorders Market by Type
11.4.7.2.2 Saudi Arabia Parathyroid Disorders Market by Diagnosis
11.4.7.2.3 Saudi Arabia Parathyroid Disorders Market by Treatment
11.4.7.2.4 Saudi Arabia Parathyroid Disorders Market by End User
11.4.7.3 U.A.E Parathyroid Disorders Market
11.4.7.3.1 U.A.E Parathyroid Disorders Market by Type
11.4.7.3.2 U.A.E Parathyroid Disorders Market by Diagnosis
11.4.7.3.3 U.A.E Parathyroid Disorders Market by Treatment
11.4.7.3.4 U.A.E Parathyroid Disorders Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Parathyroid Disorders Market Overview
11.5.2 South and Central America Parathyroid Disorders Market Forecasts and Analysis
11.5.3 South and Central America Parathyroid Disorders Market Forecasts and Analysis - By Type
11.5.4 South and Central America Parathyroid Disorders Market Forecasts and Analysis - By Diagnosis
11.5.5 South and Central America Parathyroid Disorders Market Forecasts and Analysis - By Treatment
11.5.6 South and Central America Parathyroid Disorders Market Forecasts and Analysis - By End User
11.5.7 South and Central America Parathyroid Disorders Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Parathyroid Disorders Market
11.5.7.1.1 Brazil Parathyroid Disorders Market by Type
11.5.7.1.2 Brazil Parathyroid Disorders Market by Diagnosis
11.5.7.1.3 Brazil Parathyroid Disorders Market by Treatment
11.5.7.1.4 Brazil Parathyroid Disorders Market by End User
11.5.7.2 Argentina Parathyroid Disorders Market
11.5.7.2.1 Argentina Parathyroid Disorders Market by Type
11.5.7.2.2 Argentina Parathyroid Disorders Market by Diagnosis
11.5.7.2.3 Argentina Parathyroid Disorders Market by Treatment
11.5.7.2.4 Argentina Parathyroid Disorders Market by End User
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. PARATHYROID DISORDERS MARKET, KEY COMPANY PROFILES
13.1. ALCON LABORATORIES, INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. AMGEN INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. BAYER HEALTHCARE
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. BECTON
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. DICKINSON AND COMPANY
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. ETHICON, INC.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. MEDTRONIC
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. MERCK
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. SMITH AND NEPHEW PLC
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. TEVA PHARMACEUTICAL INDUSTRIES LTD.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. Alcon Laboratories, Inc.
2. Amgen Inc.
3. Bayer Healthcare
4. Becton
5. Dickinson and Company
6. Eli Lilly, Ethicon, Inc.
7. Medtronic
8. Merck
9. Smith & Nephew plc
10. Teva Pharmaceutical Industries Ltd.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For